Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to describe the postoperative outcomes after laparoscopic transperitoneal nephrectomy and compare them with hand assisted laparoscopic nephrectomy with a focus on the limiting factors that prevent an ambulatory nephrectomy, and the benefit of our experiences from the previous study to optimize the postoperative outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ambulant Laparoscopic Nephrectomy; Are There Limiting Factors

NCT01600157

Nephrectomy

COMPLETED NA

Laparoscopic Versus Open Partial Nephrectomy - Surgical and Oncological Outcomes

NCT01093079

Tumor Nephrectomy Laparoscopy

UNKNOWN

Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics

NCT05953571

Uretro-pelvic Junction Obstruction Poorly Function Kidney

COMPLETED

Trial for Application of Laparoscopic Total Gastrectomy With Lymph Node Dissection for Gastric Cancer (KLASS-06)

NCT03385018

Gastric Cancer

RECRUITING NA

Omental Transposition Surgery for Mild Alzheimer's Disease

NCT02349191

Alzheimer's Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Laparoscopic nephrectomy

Patient with renal cell carcenoma will undergo laparoscopic nephrectomy within standarized technique

Group Type PLACEBO_COMPARATOR

Hand assisted laparoscopic nephrectomy

Intervention Type PROCEDURE

patients with renal cancer will undergo hans assisted laparoscopic nephrectomy

Hand assisted laparoscopic nephrectomy

Patient with renal cell carcenoma will undergo hand assisted laparoscopic nephrectomy

Group Type ACTIVE_COMPARATOR

Hand assisted laparoscopic nephrectomy

Intervention Type PROCEDURE

patients with renal cancer will undergo hans assisted laparoscopic nephrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hand assisted laparoscopic nephrectomy

patients with renal cancer will undergo hans assisted laparoscopic nephrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient between 25-80 years old.
2. Diagnosed as Cancer Renis
3. Can read and understand Danish
4. No cardiac disease lead to close cardiologic observations
5. Any T, any N any M stadia.

Exclusion Criteria

1. Mentally sick patient
2. Dement
3. Living alone
4. Cardiac problem
5. Per operative bleeding with the need to blood transfusion
6. Operation time at afternoon

Minimum Eligible Age

25 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No